Anavex® Life Sciences Corp. is looking for volunteers to participate in a clinical research study to examine the effects of their experimental drug. Volunteers are important for the development of new therapies and advancing our understanding of Rett syndrome. In this clinical research study volunteers will randomly receive either the study drug or placebo. This design will enable Anavex® to assess the effectiveness of the study drug. Participation in this clinical research study may last up to twelve weeks.
Anavex® Life Sciences Corp. (the “Company”) is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer’s disease, other central nervous system (“CNS”) diseases, pain and various types of cancer. Please visit us at www.anavex.com to learn more.